These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22223760)

  • 41. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting.
    Carrier M; Pellerin M; Perrault LP; Solymoss BC; Pelletier LC
    Ann Thorac Surg; 2000 Feb; 69(2):435-40. PubMed ID: 10735677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery [the ROSETTA (Routine versus Selective Exercise Treadmill Testing after Angioplasty) Registry].
    Garzon P; Sheppard R; Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Mak KH; Brown DL;
    Am J Cardiol; 2002 Feb; 89(3):251-6. PubMed ID: 11809424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of early angiographic evaluation on the frequency of emergency reoperations after coronary bypass surgery.
    Karhunen J; Raivio P; Maasilta P; Sihvo E; Suojaranta-Ylinen R; Vento A; Salminen US
    Scand J Surg; 2010; 99(3):173-9. PubMed ID: 21044936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
    Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
    J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes After Early Postoperative Myocardial Infarction Due to Graft Failure in Patients Undergoing Coronary Artery Bypass Grafting.
    Baumgarten H; Rolf A; Weferling M; Graessle T; Fischer-Rasokat U; Keller T; Kim WK; Dörr O; Nef H; Holubec T; Fichtlscherer S; Walther T; Hamm CW; Choi YH; Arsalan M; Liebetrau C
    J Invasive Cardiol; 2023 Apr; 35(4):E161-E168. PubMed ID: 36827082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.
    Domanski MJ; Mahaffey K; Hasselblad V; Brener SJ; Smith PK; Hillis G; Engoren M; Alexander JH; Levy JH; Chaitman BR; Broderick S; Mack MJ; Pieper KS; Farkouh ME
    JAMA; 2011 Feb; 305(6):585-91. PubMed ID: 21304084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.
    Oikawa FTC; Hueb W; Nomura CH; Hueb AC; Villa AV; da Costa LMA; de Melo RMV; Rezende PC; Segre CAW; Garzillo CL; Lima EG; Ramires JAF; Filho RK
    J Cardiothorac Surg; 2017 Dec; 12(1):122. PubMed ID: 29284532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol.
    Bernhardt P; Spiess J; Levenson B; Pilz G; Höfling B; Hombach V; Strohm O
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1292-300. PubMed ID: 19909933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy.
    Bahrmann P; Rach J; Desch S; Schuler GC; Thiele H
    Clin Res Cardiol; 2011 May; 100(5):457-67. PubMed ID: 21165625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
    Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B; Bolad I; Ziada K; McFalls E; Irimpen A; Truong HT; Kinlay S; Papademetriou V; Velagaleti RS; Rangan BV; Mavromatis K; Shih MC; Banerjee S; Brilakis ES
    Circ Cardiovasc Interv; 2020 Feb; 13(2):e008494. PubMed ID: 32019343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rescue percutaneous coronary intervention early after coronary artery bypass grafting in the drug-eluting stent era.
    Price MJ; Housman L; Teirstein PS
    Am J Cardiol; 2006 Mar; 97(6):789-91. PubMed ID: 16516577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.
    Arai T; Yuasa S; Miyata H; Kawamura A; Maekawa Y; Ishikawa S; Noma S; Inoue S; Sato Y; Kohsaka S; Fukuda K
    Heart Vessels; 2013 Nov; 28(6):714-9. PubMed ID: 23274577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Shyu KG; Kuan PL; Cheng JJ; Hung CR
    Am Heart J; 1998 May; 135(5 Pt 1):862-7. PubMed ID: 9588418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.
    Ivens K; Gradaus F; Heering P; Schoebel FC; Klein M; Schulte HD; Strauer BE; Grabensee B
    Int Urol Nephrol; 2001; 32(4):717-23. PubMed ID: 11989572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Choice of graft material at primary CABG influences cardiac death and reintervention rates.
    Christenson JT; Vala D; Faidutti B; Kalangos A
    Med Princ Pract; 2002; 11(3):141-6. PubMed ID: 12138296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.